Page 2 - Use Authorisation News Today

The US Food and Drug Administration (FDA) had on Tuesday (March 1) issued an advisory warning people not to use the SD Biosensor Inc. STANDARD Q Covid-19 Ag Home Test. On its website, the FDA explained that it is concerned about the risk of false results when using this test. It advised those who have used the test kit and...

The effectiveness of mRNA vaccines and antibody therapy is reduced against all three subvariants of Omicron, according to new research.The study by scientists at Columbia University and the University of Hong Kong showed that only one currently ...

New York, March 4 (IANS) The effectiveness of mRNA vaccines and antibody therapy is reduced against all three subvariants of Omicron, according to new research.

The US Food and Drug Administration (FDA) had on Tuesday (March 1) issued an advisory warning people not to use the SD Biosensor Inc. STANDARD Q Covid-19 Ag Home Test. On its website, the FDA explained that it is concerned about the risk of false results when using this test. It advised those who have used the test kit and...

While talking to ANI, Professor Hortez said, "Given the urgency, Corbevax will be helpful not only for India but globally as most of the African continent, neighbouring countries around India remain largely unvaccinated."

Dotz Nano (ASX:DTZ) shares increased 5 per cent today after an activity update to the ASX outlining two purchase orders for US$2.3 million for its SARS-CoV-2 virus detection technology and multi-country distribution agreements to be delivered in the next two years.

Data from the Governments Covid dashboard suggest the latest surge in infections peaked last Thursday, when there were just over 44,000 in a day.

India was a key vaccine exporter to Africa before it stopped the exportation to focus on fighting the local infections.

Cipla has said such an assurance will help make this significant financial commitment of more than $1 billion (over Rs 7,250 crore) advance to Moderna for its booster vaccine in India

Cipla is in advanced talks with Moderna to bring its single-dose Covid-19 vaccine to India and has appealed to the Centre to ease the process with prices, customs duty and other protocols.